Showing results (161-170 of 181) with videos related to
Sort By:
Pageof 19
Human Pathology|January 29, 1999
Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancerM Neuhaus, U Wagner, U Schmid, et al.Oncogene|January 12, 2010
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomasR Sutter, O Shakhova, H Bhagat, et al.Experimental Cell Research|April 25, 2000
Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injuryL M Sorokin, M A Maley, H Moch, et al.Oncogene|July 8, 2009
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic responseK Balamurugan, V-D Luu, M R Kaufmann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological studyD Gramatzki, P Roth, E J Rushing, et al.Cancer Research|October 5, 2001
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinomaC Morrissey, A Martinez, M Zatyka, et al.British Journal of Cancer|June 10, 2010
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotypeG Kristiansen, M Rose, C Geisler, et al.The Journal of Pathology|July 9, 1999
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancerU Wagner, K Süess, T Luginbühl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)R von Moos, B Seifert, M Simcock, et al.Journal of the National Cancer Institute|October 21, 1999
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarraysL Bubendorf, M Kolmer, J Kononen, et al.Pageof 19